Cochrane Abstracts
Sequential inactivated (IPV) and live oral (OPV) poliovirus vaccines for preventing poliomyelitis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Sequential Inactivated (IPV) and Live Oral (OPV) Poliovirus Vaccines for Preventing Poliomyelitis." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434104/all/Sequential_inactivated__IPV__and_live_oral__OPV__poliovirus_vaccines_for_preventing_poliomyelitis.
Sequential inactivated (IPV) and live oral (OPV) poliovirus vaccines for preventing poliomyelitis. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434104/all/Sequential_inactivated__IPV__and_live_oral__OPV__poliovirus_vaccines_for_preventing_poliomyelitis. Accessed December 8, 2024.
Sequential inactivated (IPV) and live oral (OPV) poliovirus vaccines for preventing poliomyelitis. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434104/all/Sequential_inactivated__IPV__and_live_oral__OPV__poliovirus_vaccines_for_preventing_poliomyelitis
Sequential Inactivated (IPV) and Live Oral (OPV) Poliovirus Vaccines for Preventing Poliomyelitis [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2024 December 08]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434104/all/Sequential_inactivated__IPV__and_live_oral__OPV__poliovirus_vaccines_for_preventing_poliomyelitis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Sequential inactivated (IPV) and live oral (OPV) poliovirus vaccines for preventing poliomyelitis
ID - 434104
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434104/all/Sequential_inactivated__IPV__and_live_oral__OPV__poliovirus_vaccines_for_preventing_poliomyelitis
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
